Exagen Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
XGN on Nasdaq
Location
1261 Liberty Way, Vista, CA

Insiders trading volume in the past year

Exagen Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
NMSIC Co-Investment Fund, L.P. 10%+ Owner $5.8M -$1.82M -23.8% Mar 25, 2025
L. Tullis James 10%+ Owner $2.73M Jun 15, 2023
Jeffrey G. Black Chief Financial Officer $2.67M -$134K -4.78% Sep 2, 2025
John Aballi President and CEO, Director $2.21M Feb 28, 2025
Kamal Adawi CFO and Corporate Secretary $466K Mar 4, 2024
Mark Hazeltine Chief Business Officer $332K Mar 2, 2023
Fortunato R. Rocca President and CEO, Director $211K Mar 1, 2022
Debra Zack Chief Medical Officer $147K Mar 1, 2022
Scott D. Kahn Director $53.7K Jun 10, 2025
Tina Susan Nova Director $48.3K Jun 10, 2025
Brian Birk Director $32.2K Jun 9, 2023
Wendy S. Johnson Director $32.2K Jun 9, 2023
Ebetuel Pallares Director $32.2K Jun 9, 2023
Ana Hooker Director $32.2K Jun 10, 2025
Paul Kim Director $32.2K Jun 10, 2025
Frank Stokes Director $32.2K Jun 10, 2025
Bruce C. Robertson Director $32.2K Jun 17, 2021

Recent Insider Transactions by Companies or Individuals for Exagen Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.